TG Therapeutics Inc (NASDAQ:TGTX)
| 29.60 Delayed Data As of 3:59pm ET |  -0.49 / -1.63%Today’s Change | 6.34 Today|||52-Week Range 31.97 | +166.67% Year-to-Date |
Latest TGTX News | Press Releases
No recent news for TG Therapeutics Inc.
Today’s Trading
| Previous close | 30.09 |
| Today’s open | 30.25 |
| Day’s range | 29.36 - 30.44 |
| Volume | 52,281 |
| Average volume (3 months) | 1,597,861 |
| Market cap | $3.9B |
Data as of 3:59pm ET, 11/24/2020
Growth & Valuation
| Earnings growth (last year) | +14.90% |
| Earnings growth (this year) | -9.55% |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | 0.00% |
| P/E ratio | NM |
| Price/Sales | 6,453.25 |
| Price/Book | 84.87 |
Competitors
| ---- | ||
| GWPHGW Pharmaceuticals P... | +3.68 | +2.93% |
| SAGESAGE Therapeutics In... | +1.81 | +2.32% |
| CCXIChemoCentryx Inc | -1.48 | -2.58% |
Data as of 4:00pm ET, 11/24/2020
Financials
| Next reporting date | March 10, 2021 |
| EPS forecast (this quarter) | -$0.53 |
| Annual revenue (last year) | $152.0K |
| Annual profit (last year) | -$172.9M |
| Net profit margin | -113,730.92% |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters New York, New York |
Forecasts
